PATENT CLAIM ANALYSIS

Application Number: 15768133
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "043000"]

Abstract:
The invention is directed to combinations of acamprosate and ribavirin, to pharmaceutical compositions, kits and treatment methods for the treatment or prevention of neurological damage.

Claim (Index 3):
The combination according to  claim 2 , wherein the ratio of acamprosate or a pharmaceutically acceptable salt thereof, and ribavirin or a pharmaceutically acceptable salt thereof, is from 50:1 to 30:1 by weight expressed as equivalent free acamprosate and equivalent free ribavirin.

Metadata:
- Claim Count in Document: 22.0
- Percentile: 91.0
- Lexical Diversity: 1.21739
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14861169', '13691981', '13706907', '14473245', '14479614']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7468421637920424
- 35 USC 102 Novelty (BERT): 0.5290620543429448
- Combined Prediction Score: 0.7250641528471327
- Mean Citation Score: 278.174786
- Max Citation Score: 286.4421
- Similarity Product: 165.005154785192

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test